Skip to main content
Duke University Libraries
View Item 
  •   DukeSpace
  • Duke Scholarly Works
  • Scholarly Articles
  • View Item
  •   DukeSpace
  • Duke Scholarly Works
  • Scholarly Articles
  • View Item
    • Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Genetic Variants of the MDM2 Gene Are Predictive of Treatment-Related Toxicities and Overall Survival in Patients With Advanced NSCLC.

    Thumbnail
    View / Download
    1.4 Mb
    Date
    2015-09
    Authors
    Qian, J
    Liu, H
    Gu, S
    Wu, Q
    Zhao, X
    Wu, W
    Wang, H
    Wang, J
    Chen, H
    Zhang, W
    Wei, Q
    Jin, L
    Lu, D
    Show More
    (13 total)
    Repository Usage Stats
    292
    views
    367
    downloads
    Abstract
    INTRODUCTION: Platinum agents can cause the formation of DNA adducts and induce apoptosis to eliminate tumor cells. The aim of the present study was to investigate the influence of genetic variants of MDM2 on chemotherapy-related toxicities and clinical outcomes in patients with advanced non-small-cell lung cancer (NSCLC). MATERIALS AND METHODS: We recruited 663 patients with advanced NSCLC who had been treated with first-line platinum-based chemotherapy. Five tagging single nucleotide polymorphisms (SNPs) in MDM2 were genotyped in these patients. The associations of these SNPs with clinical toxicities and outcomes were evaluated using logistic regression and Cox regression analyses. RESULTS: Two SNPs (rs1470383 and rs1690924) showed significant associations with chemotherapy-related toxicities (ie, overall, hematologic, and gastrointestinal toxicity). Compared with the wild genotype AA carriers, patients with the GG genotype of rs1470383 had an increased risk of overall toxicity (odds ratio [OR], 3.28; 95% confidence interval [CI], 1.34-8.02; P = .009) and hematologic toxicity (OR, 4.10; 95% CI, 1.73-9.71; P = .001). Likewise, patients with the AG genotype of rs1690924 showed more sensitivity to gastrointestinal toxicity than did those with the wild-type homozygote GG (OR, 2.32; 95% CI, 1.30-4.14; P = .004). Stratified survival analysis revealed significant associations between rs1470383 genotypes and overall survival in patients without overall or hematologic toxicity (P = .007 and P = .0009, respectively). CONCLUSION: The results of our study suggest that SNPs in MDM2 might be used to predict the toxicities of platinum-based chemotherapy and overall survival in patients with advanced NSCLC. Additional validations of the association are warranted.
    Type
    Journal article
    Subject
    Non–small-cell lung cancer
    Platinum-based chemotherapy
    Polymorphisms
    Progression-free survival
    Toxicity
    Adult
    Aged
    Aged, 80 and over
    Antineoplastic Combined Chemotherapy Protocols
    Carcinoma, Non-Small-Cell Lung
    Female
    Genetic Variation
    Humans
    Logistic Models
    Lung Neoplasms
    Male
    Middle Aged
    Platinum Compounds
    Polymorphism, Single Nucleotide
    Proportional Hazards Models
    Proto-Oncogene Proteins c-mdm2
    Survival Rate
    Treatment Outcome
    Permalink
    https://hdl.handle.net/10161/10677
    Published Version (Please cite this version)
    10.1016/j.cllc.2015.02.001
    Publication Info
    Qian, J; Liu, H; Gu, S; Wu, Q; Zhao, X; Wu, W; ... Lu, D (2015). Genetic Variants of the MDM2 Gene Are Predictive of Treatment-Related Toxicities and Overall Survival in Patients With Advanced NSCLC. Clin Lung Cancer, 16(5). pp. e37-e53. 10.1016/j.cllc.2015.02.001. Retrieved from https://hdl.handle.net/10161/10677.
    This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
    Collections
    • Scholarly Articles
    More Info
    Show full item record
    Open Access

    Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy

    Rights for Collection: Scholarly Articles

     

     

    Search Scope

    Browse

    All of DukeSpaceCommunities & CollectionsAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit DateThis CollectionAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit Date

    My Account

    LoginRegister

    Statistics

    View Usage Statistics